Third, in patients with advanced MTC, carcinoembryonic antigen (CEA) is considered as a useful biomarker for evaluation of disease progression, and for monitoring patients following thyroidectomy [9]. Here, CEACAM5 is linked to medullary thyroid gland carcinoma.